Regeneron Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US75886F1075

SecurityREGN / Regeneron Pharmaceuticals, Inc.
InstitutionPoint72 Hong Kong Ltd
ManagerSteven Cohen
Latest Disclosed Ownership11,958 shares
Latest Disclosed Value $ 6,723,625
Point72 Hong Kong Ltd ownership in REGN / Regeneron Pharmaceuticals, Inc.

On November 14, 2025 - Point72 Hong Kong Ltd filed a 13F-HR form disclosing ownership of 11,958 shares of Regeneron Pharmaceuticals, Inc. (US:REGN) valued at $6,723,625 USD as of September 30, 2025. The entity filed a previous 13F-HR on May 15, 2024 disclosing 0 shares of Regeneron Pharmaceuticals, Inc.. The current value of the position is $8,904,405 USD.

Point72 Hong Kong Ltd has a history of taking positions in derivatives of the underlying security (REGN) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

REGN / Regeneron Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 11,958 11,958 6,724 0.3086
2024-05-15 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -8,184 -100.00 0 -100.00
2024-02-14 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 8,184 8,184 7,188 0.4310
2023-02-14 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -50 -100.00 0 -100.00
2022-11-14 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 50 50 34 0.0012
2022-08-15 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -4,065 -100.00 0 -100.00
2022-05-16 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 4,065 3,294 427.24 2,839 482.96 0.0974
2022-02-14 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 771 -2,702 -77.80 487 -76.83 0.0169
2021-11-15 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 3,473 3,192 1,135.94 2,102 1,238.85 0.0683
2021-08-16 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 281 281 157 0.0051
2021-05-17 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -1,296 -100.00 0 -100.00
2021-02-16 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,296 1,296 626 0.0283
2020-08-14 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -348 -100.00 0 -100.00
2020-05-15 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 348 -137 -28.25 170 -6.59 0.0750
2020-02-14 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 485 485 39.37 182 7.06 0.0430
2019-08-14 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -136 -100.00 0 -100.00
2019-05-15 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 136 99 267.57 56 300.00 0.0221
2019-02-14 2018-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 37 37 -72.79 14 -75.00 0.0066
2018-05-15 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -42 -100.00 0 -100.00
2018-02-14 2017-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 42 42 16 0.0122
2016-11-14 2016-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -2,120 -100.00 0 -100.00
2016-08-15 2016-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 2,120 2,120 0.00 740 0.8581
2016-05-16 2016-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -20 -100.00 0 -100.00
2016-02-16 2015-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 20 20 0.00 11 0.0365
2015-05-15 2015-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -1,420 -100.00 0 -100.00
2015-02-17 2014-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,420 1,420 583 0.5758
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-02-14 2022-12-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F REGENERON PHARMACEUTICALS COM Call 3,900 290.00 2,687 354.65 n/a n/a n/a
2022-08-15 2022-06-30 13F REGENERON PHARMACEUTICALS COM Call 1,000 -56.52 591 -63.20 n/a n/a n/a
2022-05-16 2022-03-31 13F REGENERON PHARMACEUTICALS COM Call 2,300 -56.60 1,606 -52.02 n/a n/a n/a
2022-02-14 2021-12-31 13F REGENERON PHARMACEUTICALS COM Call 5,300 -39.08 3,347 -36.43 n/a n/a n/a
2021-11-15 2021-09-30 13F REGENERON PHARMACEUTICALS COM Call 8,700 262.50 5,265 292.91 n/a n/a n/a
2021-08-16 2021-06-30 13F REGENERON PHARMACEUTICALS COM Call 2,400 1,340 n/a n/a n/a
2021-05-17 2021-03-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F REGENERON PHARMACEUTICALS COM Call 500 242 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-02-14 2022-12-31 13F REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F REGENERON PHARMACEUTICALS COM Put 4,300 115.00 2,962 150.59 n/a n/a n/a
2022-08-15 2022-06-30 13F REGENERON PHARMACEUTICALS COM Put 2,000 -13.04 1,182 -26.40 n/a n/a n/a
2022-05-16 2022-03-31 13F REGENERON PHARMACEUTICALS COM Put 2,300 -55.77 1,606 -51.10 n/a n/a n/a
2022-02-14 2021-12-31 13F REGENERON PHARMACEUTICALS COM Put 5,200 0.00 3,284 4.35 n/a n/a n/a
2021-11-15 2021-09-30 13F REGENERON PHARMACEUTICALS COM Put 5,200 1.96 3,147 10.46 n/a n/a n/a
2021-08-16 2021-06-30 13F REGENERON PHARMACEUTICALS COM Put 5,100 920.00 2,849 1,102.11 n/a n/a n/a
2021-05-17 2021-03-31 13F REGENERON PHARMACEUTICALS COM Put 500 237 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.